MetaCap

Kyntra Bio Insider Trades

NASDAQ: KYNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.11+0.15 (+2.52%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $73.45K
Sales
0 · $0
Shares bought / sold
9.30K / 0
Net activity
Net buying $73,454

Kyntra Bio insider activity

Over the last 12 months, Kyntra Bio insiders reported 12 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $73,454 and sold $0 worth of stock, for net insider buying of $73,454. The most recent filing shows Wettig Thane (CEO) reporting a transaction in 209 shares at $8.55 on Sep 6, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KYNB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

KYNB insider transactions

Kyntra Bio insider transactions
DateInsiderTypeSharesValueFiling
Sep 6, 2026DeLucia DavidChief Financial OfficerTax withholding22$188.10Form 4
Sep 6, 2026Wettig ThaneCEOTax withholding209$1.79KForm 4
Jun 6, 2026DeLucia DavidChief Financial OfficerTax withholding52$348.92Form 4
Jun 6, 2026Wettig ThaneCEOTax withholding198$1.33KForm 4
May 14, 2026Wettig ThaneCEOBuy2,800$19.85KForm 4
May 14, 2026Wettig ThaneCEOBuy2,800$19.85KForm 4
Mar 6, 2026Wettig ThaneCEOTax withholding277$1.89KForm 4
Mar 6, 2026DeLucia DavidChief Financial OfficerTax withholding60$410.40Form 4
Dec 6, 2025Wettig ThaneCEOTax withholding259$2.18KForm 4
Dec 6, 2025DeLucia DavidChief Financial OfficerTax withholding52$437.84Form 4
Nov 17, 2025Wettig ThaneCEOBuy2,700$24.57KForm 4
Nov 13, 2025Wettig ThaneCEOBuy1,000$9.18KForm 4
Sep 6, 2025Wettig ThaneCEOTax withholding248$3.00KForm 4
Sep 6, 2025DeLucia DavidChief Financial OfficerTax withholding53$641.30Form 4
Jun 30, 2025Schoeneck James ADirectorBuy23,567$119.48KForm 4
Jun 6, 2025Wettig ThaneCEOTax withholding246$1.93KForm 4
Jun 6, 2025DeLucia DavidChief Financial OfficerTax withholding51$399.46Form 4
Mar 24, 2025Wettig ThaneCEOBuy145,000$50.66KForm 4
Mar 21, 2025Schoeneck James ADirectorBuy50,000$17.04KForm 4
Mar 20, 2025Schoeneck James ADirectorBuy250,000$88.00KForm 4
Mar 6, 2025DeLucia DavidChief Financial OfficerTax withholding2,325$906.75Form 4
Mar 6, 2025Wettig ThaneCEOTax withholding367$143.13Form 4
Mar 6, 2025Wettig ThaneCEOAward781—Form 4
Mar 6, 2025Wettig ThaneCEOTax withholding22,038$8.59KForm 4
Mar 6, 2025Chung ChristineSVP, CHINA OPERATIONSTax withholding422$164.58Form 4
Mar 6, 2025Chung ChristineSVP, CHINA OPERATIONSAward781—Form 4
Mar 6, 2025Chung ChristineSVP, CHINA OPERATIONSTax withholding7,008$2.73KForm 4
Dec 7, 2024Graham JuanCHIEF FINANCIAL OFFICERTax withholding1,066$364.68Form 4
Dec 6, 2024Chung ChristineSVP, CHINA OPERATIONSTax withholding2,792$955.14Form 4
Dec 6, 2024Wettig ThaneCEOTax withholding2,363$808.38Form 4
Dec 6, 2024Graham JuanCHIEF FINANCIAL OFFICERTax withholding1,446$494.68Form 4
Sep 7, 2024Graham JuanCHIEF FINANCIAL OFFICERTax withholding1,065$415.35Form 4
Sep 6, 2024Chung ChristineSVP, CHINA OPERATIONSTax withholding17,395$6.78KForm 4
Sep 6, 2024Graham JuanCHIEF FINANCIAL OFFICERTax withholding16,050$6.26KForm 4
Sep 6, 2024Wettig ThaneCEOTax withholding2,363$921.57Form 4
Aug 1, 2024Wettig ThaneCEOTax withholding20,840$9.79KForm 4
Jun 22, 2024Wettig ThaneCEOTax withholding782$883.66Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related